Degron Therapeutics logo

Degron Therapeutics

Song biological aims to become the world's leading innovative protein degradation of drugs - molecular glue type of small molecule drug research and development company. Composed of world-class management and scientific leaders with international vision and rich industry experience dage team

1

Funding Rounds

$22.0m

Money raised

Overview

Song biological aims to become the world's leading innovative protein degradation of drugs - molecular glue type of small molecule drug research and development company. Composed of world-class management and scientific leaders with international vision and rich industry experience dage team

Funding series

Funding Series Analysis

The company Degron Therapeutics has raised a total of $22m in funding over 1 rounds.

Key Insights:

  • Degron Therapeutics Series A round, June 2022: $22m
Degron Therapeutics logo
Degron Therapeutics Series A round, June 2022 $22m

Industries

Degron Therapeutics is active in the following industries: